TERRY KNUD MORGAN, MD
Medical Practice at Sam Jackson Park Rd, Portland, OR
License number
Oregon MD26195
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Phone
(503) 494-8276
Personal information
See more information about TERRY KNUD MORGAN at radaris.comName
Address
Phone
52081 SE 4Th St, Scappoose, OR 97056
Professional information
Terry Knud Morgan, Portland OR
Specialties:
Pathologist
Address:
3181 Sw Sam Jackson Park Rd, Portland, OR 97239
Education:
Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology), American Board of Pathology Sub-certificate in Cytopathology (Pathology)
Dr. Terry K Morgan, Portland OR - MD (Doctor of Medicine)
Specialties:
Cytopathology
Address:
3181 SW Sam Jackson Park Rd SUITE L-471, Portland 97239
(503) 494-8276 (Phone), (503) 494-2025 (Fax)
(503) 494-8276 (Phone), (503) 494-2025 (Fax)
Certifications:
Anatomic Pathology, 2003, Cytopathology, 2005
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
3181 SW Sam Jackson Park Rd SUITE L-471, Portland 97239
OHSU Hospital
3181 West Sam Jackson Park Rd, Portland 97239
OHSU Hospital
3181 West Sam Jackson Park Rd, Portland 97239
Education:
Medical School
University of Utah
Graduated: 1995
University of Utah
Graduated: 1995
Terry Knud Morgan, Portland OR
Specialties:
Pathology, Anatomic Pathology, Cytopathology
Work:
Oregon Health & Science University
3181 SW Sam Jackson Park Rd, Portland, OR 97239
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Education:
University of Utah (2000)
Monoclonal Antibodies Specific For Pancreatic Neoplasia Cells
US Patent:
2011017, Jul 14, 2011
Filed:
Sep 9, 2009
Appl. No.:
13/062942
Inventors:
Phillip R. Streeter - Portland OR, US
Markus Grompe - Portland OR, US
Karin M. Hardiman - Portland OR, US
Brett C. Sheppard - Portland OR, US
Christopher L. Corless - Portland OR, US
Terry K. Morgan - Portland OR, US
Markus Grompe - Portland OR, US
Karin M. Hardiman - Portland OR, US
Brett C. Sheppard - Portland OR, US
Christopher L. Corless - Portland OR, US
Terry K. Morgan - Portland OR, US
International Classification:
A61K 39/395, G01N 33/53, C12N 9/96, C12N 5/10, C12N 5/16, C12N 5/02, C12N 15/63, C07K 16/18, C07H 21/04
US Classification:
4241331, 4241411, 435 71, 435188, 435325, 435326, 435375, 435378, 4353201, 5303873, 5303881, 5303913, 5303917, 536 2353
Abstract:
Isolated monoclonal antibodies are disclosed herein that specifically bind a cell surface antigen expressed on the human pancreatic cancer cells or precancerous pancreatic cancer cells. Humanized forms of these antibodies, functional fragments of these antibodies, and hybridomas producing these antibodies are also disclosed. The antibodies can be conjugated to an effector molecule, such as a detectable marker, a therapeutic agent, or a toxin. The antibodies can be used for in vitro or in vivo pancreatic cancer diagnosis or disease monitoring via detection of pancreatic cancer cells or the pancreatic cancer cell surface antigen. Methods of treating a pancreatic cancer by administration of the antibodies are also disclosed.